Nevertheless, the effect of VHL on RAPTOR/mTORC1 complex stability suggests an additional mechanism for tumorigenesis in VHL-dependent ccRCC and part of the phenotypic variability observed in VHL disease may be due differential impact of VHL mutations on oncogenic pathways. Here, RPTOR is linked to von Hippel-Lindau disease.